Audax private equity completes sale of corevitas

Boston & san francisco--(business wire)--audax private equity (“audax”), a leading alternative investment manager and capital partner for north american middle market companies, announced today it has completed the previously announced sale of corevitas, llc (“corevitas”), a leading provider of regulatory-grade, real-world evidence (“rwe”) for approved medical treatments and therapies. thermo fisher scientific inc. (nyse: tmo) (“thermo fisher”) acquired the company in a deal that closed on augu.
TMO Ratings Summary
TMO Quant Ranking